7 results
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
1 Nov 19
Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
8:23am
, Inc., a publicly held pharmaceutical company. Before that, Mr. Daly served in various operational finance roles during his 12-year tenure at ImClone
8-K/A
EX-99.1
wfvjcvclumarqrl3vh
28 Mar 19
Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline
12:27pm
8-K
EX-99.1
r6bshdn50spidw
28 Mar 19
Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline
8:02am
- Prev
- 1
- Next